- Home
- CERT vs TLRY Comparison
CERT vs TLRY Comparison
Compare CERT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CERT | TLRY |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 808.9M | 688.9M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CERT | TLRY |
|---|---|---|
| Price | $5.43 | $4.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $11.67 | ★ $72.33 |
| AVG Volume (30 Days) | ★ 4.3M | 3.5M |
| Earning Date | 05-11-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,838,000.00 | N/A |
| Revenue This Year | $4.18 | $8.79 |
| Revenue Next Year | $5.39 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $4.45 | $0.39 |
| 52 Week High | $13.88 | $15.70 |
Technical Indicators
Market Signals| Indicator | CERT | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 31.29 |
| Support Level | $5.08 | $1.14 |
| Resistance Level | $6.37 | $5.71 |
| Average True Range (ATR) | 0.36 | 0.28 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 35.94 | 12.49 |
Price Performance
Historical ComparisonAbout CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.